Latest current cash for CHGCF: $380B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), CHGCF shows a current cash of $380B. That compares with $460B in the prior-year period — down 17.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CHGCF's current cash is now $380B (was $460B) — a 17.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Chugai Pharmaceutical , Ltd. is outperforming or lagging.
Tracking CHGCF's current cash over time shows whether Chugai Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $380B That compares with $460B in the prior-year period — down 17.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Chugai Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $380B) with ownership activity and broader fundamentals.